Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04015908 · ClinicalTrials.gov registry record · Phase 4

A Multimodal Analgesia Protocol Adapted for Ambulatory Surgery

A Phase 4 study, sponsored by University of Utah.

Completed
Registry status
Phase 4
Development phase
100
Enrollment target

NCT04015908: Completed Phase 4 study, sponsored by University of Utah.

NCT04015908 is a Phase 4 study that has completed, run by University of Utah. The registered enrollment target is 100 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04015908, a Phase 4 study, has completed, sponsored by University of Utah.

COMPLETED
Registry status
Phase 4
Development phase
100 participants
Enrollment target

Study Summary

The primary objective of this trial is to determine whether the combination of three non-opioid analgesics (multimodal analgesia) can significantly reduce or eliminate the need for opioids after ambulatory surgery. A secondary objective would be to present credible data for insurance providers about the opioid sparing effect of these medications. This data may encourage insurance providers to support payment for short term use of certain analgesics that currently require prior authorization.

Primary Outcome

Pain as measured by a 0-10 Visual Analog Scale (VAS) pain scale, where "0" is the lowest score and "10" is the highest score. For example, 10 would be severe pain and 0 would be none. Cumulative scores were the total scores over 6 days and were expressed with the absolute totals with range. No subscales were used. Cumulative scores represent the absolute sum of each data point for 6 days. The total cumulative range for pain is 0-60.

Interventions

  • DRUG Acetaminophen
  • DRUG Celecoxib
  • DRUG Oxycodone
  • DRUG Pregabalin
  • DRUG Percocet

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2019-08-01
Est. Completion 2023-01-31
Phase Phase 4
University of Utah

818 total trials

What the finished NCT04015908 record still lists

NCT04015908 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower).

The record links to 0 conditions, and to 5 interventions - of which Acetaminophen is the first listed.

NCT04015908 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04015908 about?

NCT04015908 is a clinical study titled "A Multimodal Analgesia Protocol Adapted for Ambulatory Surgery". The primary objective of this trial is to determine whether the combination of three non-opioid analgesics (multimodal analgesia) can significantly reduce or eliminate the need for opioids after ambulatory surgery. A secondary objective would be to present credible data for insurance providers abou...

What is the current status of trial NCT04015908?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2019-08-01. Estimated completion is 2023-01-31.

What interventions are being tested in trial NCT04015908?

The interventions under investigation include: Acetaminophen (DRUG), Celecoxib (DRUG), Oxycodone (DRUG), Pregabalin (DRUG), Percocet (DRUG).

Who is sponsoring clinical trial NCT04015908?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04015908's enrollment target sits among peer trials

100 770th of 2000 higher than 1,148 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04015908, the US trial registry maintained by the National Library of Medicine. NCT04015908 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.